Aviceda Therapeutics is a biotech company developing next-generation immunomodulators for ophthalmic conditions using its proprietary HALOS™ nanotechnology platform.

Beta Bionics is a medical technology company that designs, develops, and commercializes autonomous insulin delivery systems to streamline diabetes management.

Inquis Medical is a clinical-stage medical device company developing the Aventus Precision Thrombectomy System™ for treating pulmonary embolism.

Evommune, Inc. is a biotechnology company focused on developing treatments for chronic inflammatory diseases.

Pathalys Pharma is a biopharmaceutical company developing advanced therapeutics for end-stage kidney disease (ESKD).

Parse Biosciences is a company that develops and commercializes scalable single-cell sequencing technologies for use in over 1,000 labs globally, aiming to expand its product range and market presence with its recent $50 million funding.

BlueWhale Bio is a biotechnology company that specializes in overcoming bottlenecks in cell and gene therapy manufacturing.

Beta Bionics is a medical technology company that designs, develops, and commercializes autonomous insulin delivery systems to streamline diabetes management.